Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairman
Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairman Extensive private and public company corporate development track record Significant expertise in cell and gene therapy News provided by Share this article Share this article SHEFFIELD, England, Feb. 1, 2021 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, today announces the appointment of Nick Higgins as Chairman of the Board. He takes over from Dr Erica Whittaker who has served as Chair since the creation of Rinri Therapeutics. Nick's ...
Source: prnewswire.com